{
    "clinical_study": {
        "@rank": "8290", 
        "arm_group": [
            {
                "arm_group_label": "Dietary Education", 
                "arm_group_type": "Experimental", 
                "description": "Participants in this treatment arm will undergo dietary counseling for the prevention of kidney stone formation."
            }, 
            {
                "arm_group_label": "Potassium Citrate and Dietary Education", 
                "arm_group_type": "Experimental", 
                "description": "Participants in this treatment arm will undergo potassium citrate supplementation and dietary counseling for the prevention of kidney stone formation."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the role of potassium citrate supplementation with\n      dietary education versus dietary education alone in the reduction of stone risks and events\n      in patients with predominantly calcium phosphate kidney stones."
        }, 
        "brief_title": "Potassium Citrate Supplementation vs. Dietary Counseling", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Kidney Stone", 
        "condition_browse": {
            "mesh_term": [
                "Calculi", 
                "Kidney Calculi", 
                "Nephrolithiasis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients \u2265 18 years old, being seen at UNC Chapel Hill or Vanderbilt Urology Clinics\n\n          2. Documented stone analysis with \u2265 50% calcium phosphate (hydroxyapatite and/or\n             brushite) composition\n\n          3. 24 hour urine citrate (\u2264 500) on initial evaluation of at least one 24-hour urine\n             study\n\n          4. 24 hour urine pH \u2265 6.0 on initial evaluation of at least one 24-hour urine study\n\n        Exclusion Criteria:\n\n          1. Documented stone analysis with any calcium carbonate or magnesium ammonium phosphate\n             composition\n\n          2. Systemic cause for stone disease (primary hyperparathyroidism, complete distal renal\n             tubular acidosis, systemic acidosis, active urinary tract infection)\n\n          3. 24 hour urine calcium/kg (> 4) or 24 hour urine calcium/Cr (>140) on initial\n             evaluation of at least one 24-hour urine study\n\n          4. Concurrent medication therapy (potassium citrate, sodium citrate, sodium bicarbonate,\n             diuretic, angiotensin-converting enzyme inhibitor, angiotensin II receptor\n             antagonist, topiramate, acetazolamide)\n\n          5. Renal insufficiency (GFR \u2264 60)\n\n          6. Elevated serum potassium level (\u2265 4.5) or hyperkalemia\n\n          7. Low serum bicarbonate level (< 24)\n\n          8. High serum calcium level (>10)\n\n          9. Pregnancy\n\n         10. Inability to obtain informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01980004", 
            "org_study_id": "13-3010"
        }, 
        "intervention": [
            {
                "arm_group_label": "Potassium Citrate and Dietary Education", 
                "description": "20 mEq taken twice daily", 
                "intervention_name": "Potassium Citrate Supplementation", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Dietary Education", 
                    "Potassium Citrate and Dietary Education"
                ], 
                "description": "Dietary counseling will include both a verbal discussion in the clinic regarding increased fluid intake, a moderate calcium rich diet and lemonade therapy as well as receiving a written handout on these topics.", 
                "intervention_name": "Dietary Education", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Potassium Citrate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "contact": {
                "last_name": "Marisa DeBurkarte"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "North Carolina Memorial Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?", 
        "overall_contact": {
            "email": "made@med.unc.edu", 
            "last_name": "Marisa J DeBurkarte, BA", 
            "phone": "919-966-7108"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Davis J Viprakasit, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in 24-hour urine parameters", 
            "safety_issue": "No", 
            "time_frame": "4-6 weeks from baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01980004"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "collaborator": {
                "agency": "Vanderbilt University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}